Believes In – Oppose it Join BlackDoctor.org (BDO) as we sound the alarm to oppose the 340B PATIENTS Act, which – if not ...

The American Benefits Council is urging Congress to consider the cost to employers, workers and their families as it proposes ...

Vt., today introduced the 340B Patients Act, AHA-supported legislation that would codify 340B providers' ability to use ...

The pharmaceuticals lobby shored up its campaign against increasing use of the 340B Drug Discount Program with a new analysis ...

Markets only work when transparent prices reflect consumers' desires and the producers' costs. While there are complications, ...

On July 15, 2025, the Centers for Medicare & Medicaid Services (CMS) released the CY 2026 Outpatient Prospective Payment System (OPPS) proposed ...

States lost $2.3 billion in Medicaid drug rebates in 2024 due to the expanded 340B program, with Pennsylvania, Illinois, and Massachusetts hit hardest.

Overview - The Centers for Medicare & Medicaid Services (“CMS”) has finalized and proposed several significant changes affecting ...

CMS' 2026 Outpatient Prospective Payment System proposed rule includes a provision that would increase the reduction in OPPS payment rates to offset the lump sum payments previously paid to 340B ...

Senator Welch led the legislation in 2024. U.S. Representative Doris Matsui (D-CA-07) has led companion legislation in the House of Representatives. “Rural America is hit by two crises: affordability ...

The U.S. District Court for the Eastern District of Missouri July 11 granted a motion by the state to dismiss claims by ...

Lawmakers in the House and Senate introduced legislation this week that could prohibit pharmaceutical companies from restricting access to 340B drug pricing discounts. The Pharmaceutical Access to ...